BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
11/7/2014 4:41:00 PM | Browse: 1061 | Download: 700
 |
Received |
|
2014-06-11 08:27 |
 |
Peer-Review Started |
|
2014-06-11 14:15 |
 |
To Make the First Decision |
|
2014-06-27 11:51 |
 |
Return for Revision |
|
2014-06-27 19:34 |
 |
Revised |
|
2014-07-08 20:30 |
 |
Second Decision |
|
2014-08-31 16:56 |
 |
Accepted by Journal Editor-in-Chief |
|
|
 |
Accepted by Executive Editor-in-Chief |
|
2014-08-31 17:11 |
 |
Articles in Press |
|
2014-08-31 17:11 |
 |
Publication Fee Transferred |
|
|
 |
Edit the Manuscript by Language Editor |
|
|
 |
Typeset the Manuscript |
|
2014-10-23 09:56 |
 |
Publish the Manuscript Online |
|
2014-11-07 16:40 |
Category |
Transplantation |
Manuscript Type |
Minireviews |
Article Title |
T-cell ageing in end-stage renal disease patients: Assessment and clinical relevance
|
Manuscript Source |
Invited Manuscript |
All Author List |
Ruud WJ Meijers, Michiel GH Betjes, Carla C Baan and Nicolle HR Litjens |
Funding Agency and Grant Number |
|
Corresponding Author |
Ruud WJ Meijers, MSc, Department of Internal Medicine, Division of Nephrology and Transplantation, Erasmus Medical Centre, Room NA-523, PO Box 2040, 3000 CA Rotterdam, The Netherlands. r.meijers@erasmusmc.nl |
Key Words |
End-stage renal disease patients; Kidney transplantation; T-cell ageing; T-cell differentiation; Uremia |
Core Tip |
The uremia-induced inflammatory environment in end-stage renal disease (ESRD) patients is associated with a prematurely aged T-cell compartment, resulting in defective T-cell-mediated immunity. ESRD patients are highly susceptible for infections, have an increased risk for virus-associated cancers, respond poorly to vaccination and have an increased risk for atherosclerotic diseases. Adequate renal replacement therapy in the form of kidney transplantation is able to diminish the uremic pro-inflammatory environment but unsuccessfully reverses the aged T-cell system. Assessment of T-cell ageing might be a tool to facilitate individualization of immunosuppressive regimes and prevent over-immunosuppression and its associated clinical complications in kidney transplant recipients. |
Publish Date |
2014-11-07 16:40 |
Citation |
Meijers RWJ, Betjes MGH, Baan CC, Litjens NHR. T-cell ageing in end-stage renal disease patients: Assessment and clinical relevance. World J Nephrol 2014; 3(4): 268-276 |
URL |
http://www.wjgnet.com/2220-6124/full/v3/i4/268.htm |
DOI |
http://dx.doi.org/10.5527/wjn.v3.i4.268 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345